OMED
Primecap Management’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | – | Sell |
-5,451,400
| Closed | -$5.67M | – | 307 |
|
2019
Q1 | $5.67M | Sell |
5,451,400
-54,900
| -1% | -$57.1K | ﹤0.01% | 252 |
|
2018
Q4 | $4.12M | Sell |
5,506,300
-192,400
| -3% | -$144K | ﹤0.01% | 253 |
|
2018
Q3 | $12.1M | Buy |
5,698,700
+135,000
| +2% | +$286K | 0.01% | 239 |
|
2018
Q2 | $12.9M | Sell |
5,563,700
-3,200
| -0.1% | -$7.39K | 0.01% | 230 |
|
2018
Q1 | $17.7M | Buy |
5,566,900
+1,300
| +0% | +$4.13K | 0.01% | 217 |
|
2017
Q4 | $22.8M | Sell |
5,565,600
-300
| -0% | -$1.23K | 0.02% | 204 |
|
2017
Q3 | $25.2M | Buy |
5,565,900
+12,300
| +0.2% | +$55.6K | 0.02% | 195 |
|
2017
Q2 | $18.5M | Buy |
5,553,600
+3,647,000
| +191% | +$12.1M | 0.02% | 212 |
|
2017
Q1 | $17.6M | Buy |
1,906,600
+105,900
| +6% | +$975K | 0.02% | 206 |
|
2016
Q4 | $13.9M | Buy |
1,800,700
+498,000
| +38% | +$3.84M | 0.01% | 213 |
|
2016
Q3 | $14.9M | Buy |
1,302,700
+1,086,900
| +504% | +$12.4M | 0.01% | 211 |
|
2016
Q2 | $2.66M | Hold |
215,800
| – | – | ﹤0.01% | 253 |
|
2016
Q1 | $2.18M | Buy |
215,800
+24,000
| +13% | +$243K | ﹤0.01% | 256 |
|
2015
Q4 | $4.32M | Buy |
191,800
+1,000
| +0.5% | +$22.5K | ﹤0.01% | 243 |
|
2015
Q3 | $3.17M | Hold |
190,800
| – | – | ﹤0.01% | 251 |
|
2015
Q2 | $4.29M | Sell |
190,800
-15,493
| -8% | -$349K | ﹤0.01% | 238 |
|
2015
Q1 | $5.32M | Sell |
206,293
-12,107
| -6% | -$312K | 0.01% | 235 |
|
2014
Q4 | $4.75M | Hold |
218,400
| – | – | ﹤0.01% | 236 |
|
2014
Q3 | $4.13M | Sell |
218,400
-48,000
| -18% | -$909K | ﹤0.01% | 236 |
|
2014
Q2 | $6.21M | Sell |
266,400
-74,300
| -22% | -$1.73M | 0.01% | 226 |
|
2014
Q1 | $11.5M | Hold |
340,700
| – | – | 0.01% | 209 |
|
2013
Q4 | $10.1M | Buy |
340,700
+96,000
| +39% | +$2.83M | 0.01% | 214 |
|
2013
Q3 | $3.75M | Buy |
+244,700
| New | +$3.75M | ﹤0.01% | 230 |
|